Clinical Trials
Braintumor Website

There are 6 trials:
Facility: The Preston Robert Tisch Brain Tumor Center at Duke
NCT Trial Name# of Centers

NCT02764151

  First in Patient Study for PF-06840003 in Malignant Gliomas
15

NCT02664363

  EGFRvIII CAR T Cells for Newly-Diagnosed GBM
1

NCT02991456

  Rolapitant as an Antiemetic in Malignant Glioma Patients Receiving Radiotherapy and Temozolomide
1

NCT01450826

  Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide
1

NCT01954030

  Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure
1

NCT01989052

  Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites